 | • レポートコード：MRC2-11QY04353 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は予測バイオマーカーのグローバル市場について調査・分析したレポートです。種類別（がん、神経障害、心血管障害、免疫障害、その他）市場規模、用途別（診断センター、学術研究所、CRO’S、バイオ製薬会社）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別予測バイオマーカーの競争状況、市場シェア ・世界の予測バイオマーカー市場：種類別市場規模 2015年-2020年（がん、神経障害、心血管障害、免疫障害、その他） ・世界の予測バイオマーカー市場：種類別市場規模予測 2021年-2026年（がん、神経障害、心血管障害、免疫障害、その他） ・世界の予測バイオマーカー市場：用途別市場規模 2015年-2020年（診断センター、学術研究所、CRO’S、バイオ製薬会社） ・世界の予測バイオマーカー市場：用途別市場規模予測 2021年-2026年（診断センター、学術研究所、CRO’S、バイオ製薬会社） ・北米の予測バイオマーカー市場分析：米国、カナダ ・ヨーロッパの予測バイオマーカー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの予測バイオマーカー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の予測バイオマーカー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの予測バイオマーカー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Siemens Healthcare、Roche Diagnostic、G.E. Healthcare、Abbott Laboratories、Qiagen、Johnson and Johnson ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic.
The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer.
Market Analysis and Insights: Global Predictive Biomarkers Market
The global Predictive Biomarkers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Predictive Biomarkers Scope and Market Size
Predictive Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Predictive Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Siemens Healthcare
Roche Diagnostic
G.E. Healthcare
Abbott Laboratories
Qiagen
Johnson and Johnson
…
Market segment by Type, the product can be split into
Cancer
Neurological Disorder
Cardiovascular Disorder
Immunological Disorder
Others
Market segment by Application, split into
Diagnostic Centers
Academic Research Institutes
CRO’S
Bio-Pharmaceutical Companies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Predictive Biomarkers Revenue
1.4 Market by Type
1.4.1 Global Predictive Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cancer
1.4.3 Neurological Disorder
1.4.4 Cardiovascular Disorder
1.4.5 Immunological Disorder
1.4.6 Others
1.5 Market by Application
1.5.1 Global Predictive Biomarkers Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Centers
1.5.3 Academic Research Institutes
1.5.4 CRO’S
1.5.5 Bio-Pharmaceutical Companies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Predictive Biomarkers Market Perspective (2015-2026)
2.2 Global Predictive Biomarkers Growth Trends by Regions
2.2.1 Predictive Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Predictive Biomarkers Historic Market Share by Regions (2015-2020)
2.2.3 Predictive Biomarkers Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Predictive Biomarkers Market Growth Strategy
2.3.6 Primary Interviews with Key Predictive Biomarkers Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Predictive Biomarkers Players by Market Size
3.1.1 Global Top Predictive Biomarkers Players by Revenue (2015-2020)
3.1.2 Global Predictive Biomarkers Revenue Market Share by Players (2015-2020)
3.1.3 Global Predictive Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Predictive Biomarkers Market Concentration Ratio
3.2.1 Global Predictive Biomarkers Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Predictive Biomarkers Revenue in 2019
3.3 Predictive Biomarkers Key Players Head office and Area Served
3.4 Key Players Predictive Biomarkers Product Solution and Service
3.5 Date of Enter into Predictive Biomarkers Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Predictive Biomarkers Historic Market Size by Type (2015-2020)
4.2 Global Predictive Biomarkers Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Predictive Biomarkers Market Size by Application (2015-2020)
5.2 Global Predictive Biomarkers Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Predictive Biomarkers Market Size (2015-2020)
6.2 Predictive Biomarkers Key Players in North America (2019-2020)
6.3 North America Predictive Biomarkers Market Size by Type (2015-2020)
6.4 North America Predictive Biomarkers Market Size by Application (2015-2020)
7 Europe
7.1 Europe Predictive Biomarkers Market Size (2015-2020)
7.2 Predictive Biomarkers Key Players in Europe (2019-2020)
7.3 Europe Predictive Biomarkers Market Size by Type (2015-2020)
7.4 Europe Predictive Biomarkers Market Size by Application (2015-2020)
8 China
8.1 China Predictive Biomarkers Market Size (2015-2020)
8.2 Predictive Biomarkers Key Players in China (2019-2020)
8.3 China Predictive Biomarkers Market Size by Type (2015-2020)
8.4 China Predictive Biomarkers Market Size by Application (2015-2020)
9 Japan
9.1 Japan Predictive Biomarkers Market Size (2015-2020)
9.2 Predictive Biomarkers Key Players in Japan (2019-2020)
9.3 Japan Predictive Biomarkers Market Size by Type (2015-2020)
9.4 Japan Predictive Biomarkers Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Predictive Biomarkers Market Size (2015-2020)
10.2 Predictive Biomarkers Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Predictive Biomarkers Market Size by Type (2015-2020)
10.4 Southeast Asia Predictive Biomarkers Market Size by Application (2015-2020)
11 India
11.1 India Predictive Biomarkers Market Size (2015-2020)
11.2 Predictive Biomarkers Key Players in India (2019-2020)
11.3 India Predictive Biomarkers Market Size by Type (2015-2020)
11.4 India Predictive Biomarkers Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Predictive Biomarkers Market Size (2015-2020)
12.2 Predictive Biomarkers Key Players in Central & South America (2019-2020)
12.3 Central & South America Predictive Biomarkers Market Size by Type (2015-2020)
12.4 Central & South America Predictive Biomarkers Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Siemens Healthcare
13.1.1 Siemens Healthcare Company Details
13.1.2 Siemens Healthcare Business Overview
13.1.3 Siemens Healthcare Predictive Biomarkers Introduction
13.1.4 Siemens Healthcare Revenue in Predictive Biomarkers Business (2015-2020))
13.1.5 Siemens Healthcare Recent Development
13.2 Roche Diagnostic
13.2.1 Roche Diagnostic Company Details
13.2.2 Roche Diagnostic Business Overview
13.2.3 Roche Diagnostic Predictive Biomarkers Introduction
13.2.4 Roche Diagnostic Revenue in Predictive Biomarkers Business (2015-2020)
13.2.5 Roche Diagnostic Recent Development
13.3 G.E. Healthcare
13.3.1 G.E. Healthcare Company Details
13.3.2 G.E. Healthcare Business Overview
13.3.3 G.E. Healthcare Predictive Biomarkers Introduction
13.3.4 G.E. Healthcare Revenue in Predictive Biomarkers Business (2015-2020)
13.3.5 G.E. Healthcare Recent Development
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Details
13.4.2 Abbott Laboratories Business Overview
13.4.3 Abbott Laboratories Predictive Biomarkers Introduction
13.4.4 Abbott Laboratories Revenue in Predictive Biomarkers Business (2015-2020)
13.4.5 Abbott Laboratories Recent Development
13.5 Qiagen
13.5.1 Qiagen Company Details
13.5.2 Qiagen Business Overview
13.5.3 Qiagen Predictive Biomarkers Introduction
13.5.4 Qiagen Revenue in Predictive Biomarkers Business (2015-2020)
13.5.5 Qiagen Recent Development
13.6 Johnson and Johnson
13.6.1 Johnson and Johnson Company Details
13.6.2 Johnson and Johnson Business Overview
13.6.3 Johnson and Johnson Predictive Biomarkers Introduction
13.6.4 Johnson and Johnson Revenue in Predictive Biomarkers Business (2015-2020)
13.6.5 Johnson and Johnson Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Predictive Biomarkers Key Market Segments
Table 2. Key Players Covered: Ranking by Predictive Biomarkers Revenue
Table 3. Ranking of Global Top Predictive Biomarkers Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Predictive Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cancer
Table 6. Key Players of Neurological Disorder
Table 7. Key Players of Cardiovascular Disorder
Table 8. Key Players of Immunological Disorder
Table 9. Key Players of Others
Table 10. Global Predictive Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Predictive Biomarkers Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Predictive Biomarkers Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Predictive Biomarkers Market Share by Regions (2015-2020)
Table 14. Global Predictive Biomarkers Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Predictive Biomarkers Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Predictive Biomarkers Market Growth Strategy
Table 20. Main Points Interviewed from Key Predictive Biomarkers Players
Table 21. Global Predictive Biomarkers Revenue by Players (2015-2020) (Million US$)
Table 22. Global Predictive Biomarkers Market Share by Players (2015-2020)
Table 23. Global Top Predictive Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Predictive Biomarkers as of 2019)
Table 24. Global Predictive Biomarkers by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Predictive Biomarkers Product Solution and Service
Table 27. Date of Enter into Predictive Biomarkers Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Predictive Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 30. Global Predictive Biomarkers Market Size Share by Type (2015-2020)
Table 31. Global Predictive Biomarkers Revenue Market Share by Type (2021-2026)
Table 32. Global Predictive Biomarkers Market Size Share by Application (2015-2020)
Table 33. Global Predictive Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 34. Global Predictive Biomarkers Market Size Share by Application (2021-2026)
Table 35. North America Key Players Predictive Biomarkers Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Predictive Biomarkers Market Share (2019-2020)
Table 37. North America Predictive Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 38. North America Predictive Biomarkers Market Share by Type (2015-2020)
Table 39. North America Predictive Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 40. North America Predictive Biomarkers Market Share by Application (2015-2020)
Table 41. Europe Key Players Predictive Biomarkers Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Predictive Biomarkers Market Share (2019-2020)
Table 43. Europe Predictive Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Predictive Biomarkers Market Share by Type (2015-2020)
Table 45. Europe Predictive Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Predictive Biomarkers Market Share by Application (2015-2020)
Table 47. China Key Players Predictive Biomarkers Revenue (2019-2020) (Million US$)
Table 48. China Key Players Predictive Biomarkers Market Share (2019-2020)
Table 49. China Predictive Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 50. China Predictive Biomarkers Market Share by Type (2015-2020)
Table 51. China Predictive Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 52. China Predictive Biomarkers Market Share by Application (2015-2020)
Table 53. Japan Key Players Predictive Biomarkers Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Predictive Biomarkers Market Share (2019-2020)
Table 55. Japan Predictive Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Predictive Biomarkers Market Share by Type (2015-2020)
Table 57. Japan Predictive Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Predictive Biomarkers Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Predictive Biomarkers Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Predictive Biomarkers Market Share (2019-2020)
Table 61. Southeast Asia Predictive Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Predictive Biomarkers Market Share by Type (2015-2020)
Table 63. Southeast Asia Predictive Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Predictive Biomarkers Market Share by Application (2015-2020)
Table 65. India Key Players Predictive Biomarkers Revenue (2019-2020) (Million US$)
Table 66. India Key Players Predictive Biomarkers Market Share (2019-2020)
Table 67. India Predictive Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 68. India Predictive Biomarkers Market Share by Type (2015-2020)
Table 69. India Predictive Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 70. India Predictive Biomarkers Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Predictive Biomarkers Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Predictive Biomarkers Market Share (2019-2020)
Table 73. Central & South America Predictive Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Predictive Biomarkers Market Share by Type (2015-2020)
Table 75. Central & South America Predictive Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Predictive Biomarkers Market Share by Application (2015-2020)
Table 77. Siemens Healthcare Company Details
Table 78. Siemens Healthcare Business Overview
Table 79. Siemens Healthcare Product
Table 80. Siemens Healthcare Revenue in Predictive Biomarkers Business (2015-2020) (Million US$)
Table 81. Siemens Healthcare Recent Development
Table 82. Roche Diagnostic Company Details
Table 83. Roche Diagnostic Business Overview
Table 84. Roche Diagnostic Product
Table 85. Roche Diagnostic Revenue in Predictive Biomarkers Business (2015-2020) (Million US$)
Table 86. Roche Diagnostic Recent Development
Table 87. G.E. Healthcare Company Details
Table 88. G.E. Healthcare Business Overview
Table 89. G.E. Healthcare Product
Table 90. G.E. Healthcare Revenue in Predictive Biomarkers Business (2015-2020) (Million US$)
Table 91. G.E. Healthcare Recent Development
Table 92. Abbott Laboratories Company Details
Table 93. Abbott Laboratories Business Overview
Table 94. Abbott Laboratories Product
Table 95. Abbott Laboratories Revenue in Predictive Biomarkers Business (2015-2020) (Million US$)
Table 96. Abbott Laboratories Recent Development
Table 97. Qiagen Company Details
Table 98. Qiagen Business Overview
Table 99. Qiagen Product
Table 100. Qiagen Revenue in Predictive Biomarkers Business (2015-2020) (Million US$)
Table 101. Qiagen Recent Development
Table 102. Johnson and Johnson Company Details
Table 103. Johnson and Johnson Business Overview
Table 104. Johnson and Johnson Product
Table 105. Johnson and Johnson Revenue in Predictive Biomarkers Business (2015-2020) (Million US$)
Table 106. Johnson and Johnson Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Predictive Biomarkers Market Share by Type: 2020 VS 2026
Figure 2. Cancer Features
Figure 3. Neurological Disorder Features
Figure 4. Cardiovascular Disorder Features
Figure 5. Immunological Disorder Features
Figure 6. Others Features
Figure 7. Global Predictive Biomarkers Market Share by Application: 2020 VS 2026
Figure 8. Diagnostic Centers Case Studies
Figure 9. Academic Research Institutes Case Studies
Figure 10. CRO’S Case Studies
Figure 11. Bio-Pharmaceutical Companies Case Studies
Figure 12. Predictive Biomarkers Report Years Considered
Figure 13. Global Predictive Biomarkers Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Predictive Biomarkers Market Share by Regions: 2020 VS 2026
Figure 15. Global Predictive Biomarkers Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Predictive Biomarkers Market Share by Players in 2019
Figure 18. Global Top Predictive Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Predictive Biomarkers as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Predictive Biomarkers Revenue in 2019
Figure 20. North America Predictive Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Predictive Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Predictive Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Predictive Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Predictive Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Predictive Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Predictive Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
ゲノミクスバイオマーカーの世界市場（～2026年） A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characterist…- がん分子バイオマーカーの世界市場（～2026年） Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluid…
- EPOバイオマーカーの世界市場（～2026年） Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers are used to increase the growth of red blood cells in the body by stimulating the bone marrow. Major factors contributing to the growth of the global EPO biomarkers market include increasing sede…
- 血清がんバイオマーカーの世界市場（～2026年） Serum biomarkers are proteins generally detected in urine, blood, and other bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within…
- 糖尿病性神経障害治療薬の世界市場（～2026年） A drug used to treat mental illness caused by diabetes Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CA…